KEGG   DRUG: Oportuzumab monatox
Entry
D11913                      Drug                                   
Name
Oportuzumab monatox (USAN)
Formula
C3072H4731N877O952S12
Exact mass
69523.5397
Mol weight
69565.54
Sequence
HHHHHHDIQM TQSPSSLSAS VGDRVTITCR STKSLLHSNG ITYLYWYQQK PGKAPKLLIY
QMSNLASGVP SRFSSSGSGT DFTLTISSLQ PEDFATYYCA QNLEIPRTFG QGTKVELKRA
TPSHNSHQVP SAGGPTANSG TSGSEVQLVQ SGPGLVQPGG SVRISCAASG YTFTNYGMNW
VKQAPGKGLE WMGWINTYTG ESTYADSFKG RFTFSLDTSA SAAYLQINSL RAEDTAVYYC
ARFAIKGDYW GQGTLLTVSS EFGGAPEFPK PSTPPGSSGL EGGSLAALTA HQACHLPLET
FTRHRQPRGW EQLEQCGYPV QRLVALYLAA RLSWNQVDQV IRNALASPGS GGDLGEAIRE
QPEQARLALT LAAAESERFV RQGTGNDEAG AASADVVSLT CPVAAGECAG PADSGDALLE
RNYPTGAEFL GDGGDVSFST RGTQNWTVER LLQAHRQLEE RGYVFVGYHG TFLEAAQSIV
FGGVRARSQD LDAIWRGFYI AGDPALAYGY AQDQEPDARG RIRNGALLRV YVPRSSLPGF
YRTGLTLAAP EAAGEVERLI GHPLPLRLDA ITGPEEEGGR LETILGWPLA ERTVVIPSAI
PTDPRNVGGD LDPSSIPDKE QAISALPDYA SQPGKPPHHH HHHKDEL
(Disulfide bridge: 29-99, 166-240, 294-316, 401-408)
  Type
Peptide
Remark
ATC code: L01FX16
Efficacy
Antineoplastic
  Type
Antibody-drug conjugate
Comment
Antibody-toxin conjugate
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    L01FX Other monoclonal antibodies and antibody drug conjugates
     L01FX16 Oportuzumab monatox
      D11913  Oportuzumab monatox (USAN)
Other DBs
CAS: 945228-48-8
PubChem: 497620326
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system